Publication	Data		Fish	Anatomy
Quint et al., 2023	Figure 4		lama2re16/re16	eye increased diameter, abnormal
	Figure 5		lama2re16/re16	eye refractivity, abnormal
Smith et al., 2021	Fig. 10		lama2teg15a/teg15a	muscle dystrophic, abnormal muscle refractivity, abnormal protein ubiquitination increased occurrence, abnormal swimming behavior decreased process quality, abnormal
	Fig. 2		lama2teg15a/teg15a	lysosome localization disrupted, abnormal myotome lysosome displaced to myoseptum, abnormal
	Fig. 5		lama2teg15a/teg15a	myotome lysosome increased amount, abnormal
	Fig. 8		lama2teg15a/teg15a	autophagy increased occurrence, abnormal
Hall et al., 2019	Fig. 1		lama2teg15a/teg15a	muscle cell apoptotic, abnormal muscle cell detached from muscle basement membrane, abnormal muscle cell dystrophic, abnormal sarcomere organization onset quality, abnormal
	Fig. 5		lama2teg15a/teg15a; i150Tg	myotome muscle stem cell decreased amount, abnormal
Wood et al., 2018	Fig. 7		lama2teg15a/teg15a	myotome morphology, abnormal vertical myoseptum col1a1a expression decreased amount, abnormal
Smith et al., 2017	Fig. 1		lama2teg15a/teg15a	musculoskeletal movement decreased magnitude, abnormal thigmotaxis disrupted, abnormal
	Fig. 2		lama2teg15a/teg15a	muscle refractivity, abnormal somite muscle cell detached from somite, abnormal trunk musculature degenerate, abnormal
	Fig. 5		lama2teg15a/teg15a	skeletal muscle cell filamentous actin aggregated, abnormal
	Fig. S1		lama2cl501/cl501	musculoskeletal movement decreased magnitude, abnormal thigmotaxis disrupted, abnormal
Li et al., 2015	Fig. 2		lama2teg15a/teg15a	skeletal muscle cell disorganized, abnormal skeletal muscle disorganized, abnormal skeletal muscle structure, abnormal
	Fig. 3		lama2teg15a/teg15a	skeletal muscle structure, abnormal
	Fig. 4		lama2teg15a/teg15a	skeletal muscle decreased strength, abnormal
	Fig. 5		lama2teg15a/teg15a	skeletal muscle decreased strength, abnormal
Petersen et al., 2015	Fig. 5		WT + MO1-lama2	posterior lateral line myelination of posterior lateral line nerve axons decreased occurrence, abnormal posterior lateral line Schwann cell development decreased process quality, abnormal
Charvet et al., 2013	Fig. 2		AB/TU + MO1-lama2	myotome dystrophic, abnormal skeletal muscle tissue development decreased process quality, abnormal
Gupta et al., 2012	Fig. 1		lama2cl501/cl501 (AB)	muscle degenerate, abnormal muscle disorganized, abnormal somite disorganized, abnormal whole organism decreased size, abnormal
	Fig. 2		lama2cl501/cl501 (AB)	muscle dystrophic, abnormal myoseptum broken, abnormal myotome decreased size, abnormal skeletal muscle cell M band disorganized, abnormal skeletal muscle cell myofibril detached from myotome muscle tendon junction, abnormal skeletal muscle cell myofibril detached from skeletal muscle cell myofibril, abnormal skeletal muscle cell Z disc disorganized, abnormal skeletal muscle morphology, abnormal
	Fig. 3		lama2cl501/cl501 (AB)	muscle degenerate, abnormal muscle disorganized, abnormal
	Fig. 4		lama2cl501/cl501 (AB)	brain decreased size, abnormal brain morphology, abnormal eye decreased size, abnormal eye morphology, abnormal
	text only		lama2cl501/cl501 (AB)	swimming decreased rate, abnormal whole organism decreased speed, abnormal whole organism viability, abnormal
Sztal et al., 2012	Fig. 1		lama2teg15a/teg15a	muscle damaged, abnormal muscle dystrophic, abnormal myotome refractivity, abnormal skeletal muscle cell detached from myoseptum, abnormal
	Fig. 2		lama2teg15a/teg15a	fast muscle cell detached from myoseptum, abnormal slow muscle cell detached from myoseptum, abnormal
	Fig. 3		lama2teg15a/teg15a; i108Tg ,   lama2teg15a/teg15a	myotome refractivity, abnormal slow muscle cell detached from myoseptum, abnormal
	Fig. 4		lama2teg15a/teg15a	apoptotic process delayed, abnormal myotome morphology, abnormal myotome refractivity, abnormal skeletal muscle cell apoptotic, abnormal slow muscle cell detached from myoseptum, abnormal
Gupta et al., 2011	Fig. 1		lama2teg15a/teg15a (AB)	myotome skeletal muscle degenerate, abnormal skeletal muscle fiber development process quality, abnormal
Williams et al., 2011	Fig. 4		lama2teg15a/teg15a; pc10Tg	muscle dystrophic, abnormal
Jacoby et al., 2009	Fig. 1		lama2teg15a/teg15a	myotome skeletal muscle cell decreased amount, abnormal myotome skeletal muscle cell degeneration, abnormal
Hall et al., 2007	Fig. 1		lama2teg15a/teg15a	muscle organ development disrupted, abnormal myotome structure, abnormal skeletal muscle cell detached from vertical myoseptum, abnormal skeletal muscle cell dystrophic, abnormal skeletal muscle cell retracted, abnormal
	Fig. 3		WT + MO3-lama2 ,   lama2teg15a/teg15a ,   WT + MO1-lama2	muscle organ development disrupted, abnormal myotome structure, abnormal
	Fig. 4		lama2teg15a/teg15a	myotome extracellular matrix structure, abnormal skeletal muscle cell detached from vertical myoseptum, abnormal skeletal muscle cell retracted, abnormal
	Fig. 5		lama2teg15a/teg15a	vertical myoseptum deformed, abnormal
Phenotype Annotation (1994-2006)	Fig. for (teg15a)		lama2teg15a	somite degenerate, abnormal trunk musculature quality, abnormal
	Fig. for (tk209)		lama2tk209	musculoskeletal movement disrupted, abnormal somite quality, abnormal trunk musculature quality, abnormal
Granato et al., 1996	Table 1		lama2teg15a/teg15a ,   lama2tk209/tk209	larval locomotory behavior decreased rate, abnormal myotome degenerate, abnormal myotome refractivity, abnormal thigmotaxis decreased rate, abnormal